Malla Reddy Narayana Hospital, Hyderabad Successfully Treats Rare Primary Peritoneal Ewing’s Sarcoma with Advanced HIPEC Surgery
Hyderabad, India — In a groundbreaking achievement, Malla Reddy Narayana Hospital, a leading multispecialty medical facility in Hyderabad, has successfully treated a rare and aggressive form of cancer — Primary Peritoneal Ewing's Sarcoma — using HIPEC (Hyperthermic Intraperitoneal Chemotherapy) surgery. This marks a significant milestone in India's oncology landscape, offering new hope to patients battling rare intra-abdominal cancers.
What Is Primary Peritoneal Ewing’s Sarcoma?
Ewing's Sarcoma is a rare type of cancer typically found in bones or soft tissues. However, when it arises in the peritoneal cavity, it is classified as Primary Peritoneal Ewing's Sarcoma — an extremely rare and aggressive form that poses significant challenges in diagnosis and treatment.
A Rare Diagnosis, A Bold Treatment
The patient, a young adult, presented with severe abdominal discomfort and swelling. After extensive diagnostic procedures including biopsy, imaging scans, and molecular testing, the oncology team at Malla Reddy Narayana Hospital identified the tumor as Primary Peritoneal Ewing's Sarcoma — a condition with limited treatment protocols globally.
Given the rarity and severity of the case, the expert team led by Dr. [Insert Oncologist’s Name], Head of Surgical Oncology, chose to proceed with HIPEC surgery — an advanced treatment involving the circulation of heated chemotherapy drugs within the abdominal cavity immediately after tumor removal.
HIPEC: A Life-Saving Technology
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a state-of-the-art procedure used for treating cancers that have spread within the abdomen. After surgical removal of visible tumors, a heated chemotherapy solution is infused directly into the abdominal cavity to kill microscopic cancer cells — a technique proven to significantly improve survival rates in select cancers.
"Performing HIPEC on a rare sarcoma like this is highly complex, but we were confident in our expertise and infrastructure. The patient responded exceptionally well," said Dr. [Name], Surgical Oncologist.
Patient Recovery and Outcome
Post-surgery, the patient showed remarkable recovery and is now undergoing follow-up therapy and monitoring under the hospital’s multidisciplinary cancer care team. Early results indicate a positive prognosis, marking the procedure a resounding success.
Advancing Oncology in India
This case underscores Malla Reddy Narayana Hospital’s commitment to pioneering advanced cancer care and providing cutting-edge treatments even for the rarest of cases.
"This success story is a beacon of hope and a testament to the strength of our oncology program," said Dr. [Hospital Director's Name], Director of Malla Reddy Narayana Hospital.
About Malla Reddy Narayana Hospital
Located in Hyderabad, Malla Reddy Narayana Hospital is a NABH-accredited facility known for excellence in multi-specialty care. The hospital boasts state-of-the-art technology and a renowned team of doctors across departments including oncology, cardiology, neurology, and critical care.
📌 Key Highlights
Rare case of Primary Peritoneal Ewing’s Sarcoma successfully treated
HIPEC surgery performed for advanced intra-abdominal cancer
A breakthrough in Indian oncology treatment
Demonstrates Malla Reddy Narayana Hospital’s advanced surgical and oncological capabilities
Get Instant Loan Approval with Vizzve Financials!
Need a personal, business, or home loan? Vizzve Financials offers quick approvals, minimal paperwork, and the best interest rates for hassle-free financing.
Why Choose Us?
✅ All Loan Types – Personal, Business, Home & More
✅ Fast Approvals – Get funds when you need them
✅ No Hidden Charges – 100% transparency
✅ Best Interest Rates – Affordable repayment options
We Don’t Just Promise – We Deliver! Get the best loan deals
Ewing's Sarcoma
Primary Peritoneal Sarcoma
HIPEC Surgery
Rare Cancer Treatment
Malla Reddy Narayana Hospital
Advanced Oncology Treatment
Cancer Care in Hyderabad
Oncological Breakthrough India